Phase IV Study of Boosted Atazanavir (ATV) Versus Non-Boosted ATV in Naive Patients
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir (Primary) ; Lamivudine; Stavudine
- Indications HIV infections
- Focus Therapeutic Use
- 01 May 2009 Week-96 body composition data published in Clinical Infectious Diseases.
- 25 Jul 2007 Results to 96 weeks were reported at IAS.
- 28 Feb 2007 Interim results at 48 weeks have been reported.